Aveanna Healthcare Holdings Inc. (AVAH) Stock Forecast
AVAH analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.27 / 5 from 11 analysts
- Price target
- $14.85 average of analyst targets
- Upside to target
- +20.3% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.19
- 52-week range
- $6.22 – $14.38
AVAH analyst ratings
11 analystsNumber of analysts at each rating.
AVAH price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
AVAH earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.21 | $0.19 | $0.23 | $0.15 | +38.3% | 10 |
| Current fiscal year (2026) | $0.82 | $0.79 | $0.86 | $0.60 | +37.4% | 11 |
| Next fiscal year (2027) | $0.91 | $0.82 | $0.96 | $0.82 | +10.1% | 11 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
AVAH revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $680.6M | $669.4M | $691.7M | +9.4% | 9 |
| Current fiscal year (2026) | $2.69B | $2.68B | $2.72B | +10.7% | 10 |
| Next fiscal year (2027) | $2.90B | $2.87B | $2.94B | +7.6% | 10 |
AVAH EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
AVAH revenue: reported and forecast
AVAH EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.17 | $0.17 | $0.20 | $0.21 | $0.21 | +20.3% | 2 up · 0 down |
| Current fiscal year (2026) | $0.71 | $0.71 | $0.82 | $0.82 | $0.82 | +16.8% | 1 up · 0 down |
| Next fiscal year (2027) | $0.77 | $0.78 | $0.90 | $0.91 | $0.91 | +17.2% | 2 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
AVAH earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; AVAH beat in 11 of 12.
What analysts expect from AVAH
11 analysts cover Aveanna Healthcare; their consensus rating is buy (4.27 on a 1–5 scale, where 5 is a strong buy). The average price target is $14.85, 20.3% above the latest close of $12.34. Analysts expect earnings of $0.82 per share for 2026, +37.4% from a year earlier. For 2027 the average estimate is $0.91 per share on revenue of $2.9 billion. Aveanna Healthcare beat the EPS estimate in 11 of the last 12 quarters.
Related: AVAH income statement, AVAH key metrics, AVAH chart. See the AVAH stock overview for the latest quote and news.
AVAH forecast FAQ
What is Aveanna Healthcare's price target?
The average analyst price target for Aveanna Healthcare is $14.85, 20.3% above the latest close of $12.34.
Is Aveanna Healthcare a buy, hold or sell?
Of 11 analysts covering Aveanna Healthcare, 6 rate it a strong buy, 2 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Aveanna Healthcare's EPS forecast?
Analysts forecast $0.82 per share for 2026 (range $0.79 to $0.86); for 2027 the estimate is $0.91.
What is Aveanna Healthcare's revenue forecast?
The average revenue estimate for 2026 is $2.7 billion, growth of 10.7%; for 2027 it is $2.9 billion.
When does Aveanna Healthcare report earnings?
Aveanna Healthcare is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $0.19.
Does Aveanna Healthcare usually beat earnings estimates?
Aveanna Healthcare reported EPS at or above the analyst estimate in 11 of the last 12 quarters.